Germany factory output falls to lowest since pandemic in 2020
Factory output fell 1.9 percent month-on-month, federal statistics agency Destatis said, steeper than a drop of 0.5 percent forecast by analysts polled by financial data firm FactSet.
There were particularly heavy falls in the machinery and pharmaceutical sectors, helping to drag overall output down to levels last seen in May 2020 during the coronavirus pandemic.
Destatis also made a major revision to May industrial production data, saying the indicator fell 0.1 percent. It had previously reported a healthy rise of 1.2 percent.
ING bank analyst Carsten Brzeski said the dire data could prompt a downward revision to an already poor initial estimate showing that the economy shrank slightly in the second quarter.
"This is bad news," he said. "At face value, industry remains stuck in a very long bottoming out."
- Political setback -
Fixing the eurozone's traditional export powerhouse has been a key priority for Germany's conservative Chancellor Friedrich Merz, with the economy battered in recent years by high energy costs and fierce Chinese competition.
Plans to spend hundreds of billions of euros on infrastructure upgrades and rearmament -- combined with a series of brighter data releases since the start of the year -- had raised hopes that the worst might be over for Europe's export champion.
German business morale rose to its highest level in July after seven straight increases, while think tanks including the respected DIW institute have revised growth forecasts up for 2025 and 2026.
But hard data on business activity has been mixed, raising fears that the improved mood was down to unfounded optimism.
Some experts say better data early in the year was the temporary effect of US "front-loading" as American customers rushed to get orders in before Trump's tariffs took effect.
"Optimism still seems to be based on a big portion of wishful thinking and is not at all matched by current data," Brzeski said.
"For now, what looked like a cyclical rebound in the making has only been US front-loading."
Pointing to increased investment and an uptick in retail sales, however, Berenberg analyst Holger Schmieding said there were signs of green shoots for the German economy.
"The situation at home seems to be stabilising," he said. "German consumers are opening their wallets at least cautiously."
- Tariff troubles -
A new baseline US levy of 15 percent on EU exports took effect Thursday, up from 10 percent in effect since April, stiffening the tariff faced by Germany's exporters even while leaving many of them mired in uncertainty.
Export data released Thursday showed that German exports in June to the United States -- the country's biggest trading partner -- fell 2.1 percent, even as they rose 0.8 percent worldwide.
And data released Wednesday showed that industrial orders -- closely watched as an indicator of future business activity -- fell 1.0 percent month-on-month in June, after dropping 0.8 percent in May.
The United States is also carrying out investigations into sectors including pharmaceuticals and semiconductor equipment, heightening worries about worse to come.
"The tariffs are a big burden for German companies," the head of the German chambers of commerce, Helena Melnikov, told AFP. "Don't forget that tariffs were usually between zero and about two percent at the most beforehand."
"It could even come out worse for a variety of sectors because negotiations are ongoing," she added. "It is a real setback and makes it harder to do business in Germany."
vbw/fz/rl
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 minutes ago
- Yahoo
Relief Therapeutics Advances Publication of 2025 Half-Year Report
GENEVA, SWITZERLAND / / August 11, 2025 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY ) (Relief, or the Company), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, today announced that it has advanced the publication date of its 2025 half-year report. Originally scheduled for release on August 27, 2025, the report will now be published on August 14, 2025, ahead of market opening. The change in publication date is due to the Company's anticipated early completion of the report. The half-year report, which will include a shareholder update and interim financial statements, will be available on Relief's website at the time of publication. ABOUT RELIEFRelief is a commercial-stage biopharmaceutical company dedicated to advancing treatment paradigms and improving the lives of patients with rare and debilitating diseases. With core expertise in drug delivery systems and drug repurposing, Relief's clinical pipeline includes innovative treatments designed to address critical unmet medical needs in rare dermatological, metabolic and respiratory conditions. The Company has also successfully brought several approved products to market through licensing and distribution partnerships. Headquartered in Geneva, Relief is listed on the SIX Swiss Exchange under the symbol RLF and quoted in the U.S. on OTCQB under the symbols RLFTF and RLFTY. For more information, visit CONTACTRELIEF THERAPEUTICS Holding SAJeremy MeinenChief Financial Officercontact@ SOURCE: Relief Therapeutics Holding SA View the original press release on ACCESS Newswire Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Bloomberg
7 minutes ago
- Bloomberg
Orsted Plans $9 Billion Rights Issue to Strenghen Balance Sheet
Orsted A/S said it will conduct a rights issue to raise as much as 60 billion Danish kroner ($9.4 billion). The offering, which confirms a Bloomberg News report from Friday, will help the Danish renewable-power giant shore up its balance sheet after a challenging period in recent years. The rights issue has the support of the Danish state, which is the company's majority shareholder.


Bloomberg
7 minutes ago
- Bloomberg
Nvidia China Chip Payments, Tax Hike Hurts Jobs, Private Credit's Losers
Your morning briefing, the business news you need in just 15 minutes. On today's podcast: (1) Nvidia and Advanced Micro Devices agreed to pay 15% of their revenues from Chinese AI chip sales to the US government in a deal to secure export licenses, an unusual arrangement that may unnerve both US companies and Beijing. (2) European nations are seeking to talk to Donald Trump ahead of the US president's planned meeting in Alaska with Russian leader Vladimir Putin, according to people familiar with the matter. (3) Israeli Prime Minister Benjamin Netanyahu defended his plan for a military sweep against the final Hamas strongholds in Gaza, calling it the best available option for recovering hostages while safeguarding his country's long-term security — an argument that's met vocal opposition at home and abroad. (4) It was a 'trailblazing' project - and for the two small pension funds that helped finance it, a chance to prop up the retirement savings of dentists and pharmacists in rural northern Germany. We look at Germany's biggest property crash since the financial crisis. (5) The UK jobs market weakened across the board in July as employers cut their payroll budgets in response to Chancellor of the Exchequer Rachel Reeves' £26 billion ($34.9 billion) tax increase, according to a survey closely monitored by the Bank of England. (6) European Central Bank officials will wait until December to deliver their next interest-rate cut in what is likely to be the final move in the cycle, a Bloomberg survey showed.